Koga N, Satoh T, Watanabe K, Kohchi K, Iwata Y, Minami H
Department of Cardiology, Koga Hospital, Kurume City, Japan.
Biomater Artif Cells Immobilization Biotechnol. 1991;19(1):37-52. doi: 10.3109/10731199109117814.
We have evaluated the effects of LDL-aphereses performed over 15 to 62 months, involving both Double Filtration Plasmapheresis (DFPP) and LDL Adsorbent Plasmapheresis (LAPP), for 5 patients with familial hypercholesterolemia (FH) (1; homozygous, and 4; heterozygous) using computer image analysis by coronary angiography, (CAG). Results by CAG showed that in homozygous FH, 9 (75%) of 12 segments demonstrated no progression, 2 (16.7%) segments showed regression, and only 1 (8.3%) segment showed progression. In heterozygous FH, 27 (81.8%) of 33 segments showed progression, and 6 (18.2%) segments showed regression. Aorto coronary bypass was beneficial with obtained patency in 13 (93%) of the 14 grafts. We also performed an autopsy on one patient, with heterozygous FH who died suddenly probably due to fibrillation. The patient had received long-term LDL apheresis for 6 years and 7 months and had shown angiographic regression. The pathological findings showed no typical or new atheroma, significant cicatrization in the thickened intima and an eccentric thickened wall lesion. The serial angiographic findings together with the pathological findings very clearly support the use of LDL-apheresis for producing "true" regression in coronary atherosclerosis in FH.
我们对5例家族性高胆固醇血症(FH)患者(1例纯合子,4例杂合子)进行了15至62个月的低密度脂蛋白分离治疗效果评估,治疗方法包括双重滤过血浆置换(DFPP)和低密度脂蛋白吸附血浆置换(LAPP),采用冠状动脉造影(CAG)计算机图像分析技术。CAG结果显示,在纯合子FH患者中,12个节段中有9个(75%)无进展,2个节段(16.7%)出现消退,仅1个节段(8.3%)有进展。在杂合子FH患者中,33个节段中有27个(81.8%)有进展,6个节段(18.2%)出现消退。14例移植血管中有13例(93%)的主动脉冠状动脉旁路移植术通畅。我们还对1例杂合子FH患者进行了尸检,该患者可能因房颤突然死亡。该患者接受了6年7个月的长期低密度脂蛋白分离治疗,血管造影显示有消退。病理检查结果显示无典型或新的动脉粥样硬化,增厚的内膜有明显瘢痕形成,且有偏心性增厚的壁病变。连续的血管造影结果和病理检查结果非常明确地支持在FH患者的冠状动脉粥样硬化中使用低密度脂蛋白分离治疗以产生“真正的”消退。